Avantor (AVTR) Cash from Financing Activities (2018 - 2026)
Avantor's (AVTR) quarterly Cash from Financing Activities came in at -$107.2 million in Q1 2026, down 219.05% year-on-year from $90.0 million in Q1 2025, and down 15414.29% quarter-over-quarter from $700000.0 in Q4 2025.
Avantor (AVTR) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Avantor's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$107.2 million for Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 219.05% year-over-year to -$107.2 million in Q1 2026; TTM through Mar 2026 was -$483.0 million, a 59.23% increase from a year earlier, with the FY2025 full-year figure at -$409.4 million, up 68.05% from the prior year.
- Cash from Financing Activities fell to -$107.2 million in Q1 2026 per AVTR's latest filing, from $700000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $700000.0 in Q4 2025 and bottomed at -$755.3 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$188.4 million (2023), against an average of -$193.5 million.
- Across the five-year window, Cash from Financing Activities plunged 310.27% in 2024 and surged 100.09% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$81.6 million in 2022, then slumped by 125.61% to -$184.1 million in 2023, then plunged by 310.27% to -$755.3 million in 2024, then jumped by 100.09% to $700000.0 in 2025, then plunged by 15414.29% to -$107.2 million in 2026.
- Per Business Quant, the three latest AVTR Cash from Financing Activities figures stand at -$107.2 million (Q1 2026), $700000.0 (Q4 2025), and -$369.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | -107.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.20 Mn |
| Mar 31, 2026 | -107.20 Mn |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | -369.60 Mn |
| Sep 30, 2025 | -369.60 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Mar 31, 2024 | -130.20 Mn |
| Mar 31, 2024 | -130.20 Mn |
| Dec 31, 2023 | -184.10 Mn |
| Dec 31, 2023 | -184.10 Mn |